Sign Up to like & get
recommendations!
1
Published in 2022 at "Stroke"
DOI: 10.1161/strokeaha.122.040219
Abstract: Stroke burden is substantially increasing but current therapeutic drugs are still far from ideal. Here we highlight the vast potential of staphylokinase as an efficient, fibrin-selective, inexpensive, and evolvable thrombolytic agent. The emphasis is escalated…
read more here.
Keywords:
widely accessible;
accessible thrombolytic;
highly efficient;
staphylokinase ... See more keywords